Rabi Hanna, MD
Pediatric Cellular TherapyPediatric Hematologic Malignancy
Highlights
Age Groups Seen
- Child
- Adolescent
- Adult
Languages
- Assyrian
- Aramaic
- Arabic
- English
Gender
MaleAbout Rabi Hanna
Title
Chair
Biography
Rabi Hanna, M.D. is the chairman of the Division of Pediatric Hematology & Oncology and BMT at Cleveland Clinic Children's. Dr. Hanna is the founding director of the pediatric Blood & Marrow Transplant program Cleveland Clinic Children's. He has more than 15 years of experience treating complicated high risk blood cancer, immune deficiencies, hemoglobinopathies, inherited disorders that require BMT as life-saving therapy. He is a member of the National Comprehensive Cancer Network (NCCN) Pediatric Lymphoma Committee, which sets treatment guidelines for pediatric aggressive lymphoma across the United States. He also is member of Childhood cancer alliance as
Dr. Hanna is board certified in Pediatrics and Pediatric Hematology-Oncology. He earned his medical degree from Aleppo University Faculty of Medicine in Aleppo, Syria. His post-graduate training in USA includes a pediatric residency at Duke University Medical Center in Durham, North Carolina, and a pediatric hematology-oncology fellowship at the Fred Hutchinson Cancer Research Center and Seattle Children's Hospital in Seattle, Washington. After finishing fellowship training, Dr. Hanna joined Cleveland Clinic as an assistant professor and established the pediatric BMT program in 2011. H later served as the director of the pediatric hematology-oncology fellowship program between 2014-2017.
Dr. Hanna been involved with several national clinical trials to improve access to bone marrow transplant, cellular and gene therapies. His clinical research is aimed at identifying genetic factors that affect outcomes post bone marrow transplantation and improving Gene Therapy outcomes for patients with sickle cell disease or other genetic disorders. Dr. Hanna is a member of several professional organizations, including the American Society of Pediatric Hematology Oncology, American Society of Hematology, and the American Society of Bone Marrow Transplant.
Dr. Hanna has contributed more than 100 papers and presentations at national and international meetings and has had his work published in journals such as Blood, Journal of Clinical Oncology, JAMA Oncology and NEJM evidence.
Dr. Hanna's primary focus and passion is taking care of patients with cancer or blood disorders.
Locations
- Cleveland Clinic Children's Outpatient Center
- 8950 Euclid Avenue, Cleveland, OH 44106
- Get Directions
Education & Board Certifications
Education
- Fellowship: Fred Hutchinson Cancer Research Center, 2010
- Residency: Duke University Medical Center , 2007
- Medical Education: Aleppo University Faculty of Medicine, 2001
Board Certifications
- Pediatric Hematology-Oncology: American Board of Pediatrics, 2011
- Pediatrics: American Board of Pediatrics, 2007
Professional Highlights
- Chairman, Cleveland Clinic Children's, Department of Pediatric Hematology & Oncology and BMT - 2017 to present
- Associate Professor, Cleveland Clinic Lerner College of Medicine
- Co-Director, Pediatric Cancer Program, Cleveland Clinic (2019-Present)
- Member, NCCN B-Cell Lymphoma
- Co-Director, Cleveland Clinic Comprehensive Breast Cancer Program (2013-2019)
- Co-Principal Investigator, CTN clinical trial 1204
- Co-Principle Investigator BMT CTN clinical trial 1507
Manuscript Reviewer:
- Transplant and Cellular Therapy Journal
- Blood Advance
- Lancet Oncology
- Pediatric Blood & Cancer
- Nature Genetics
Elected Member of BMT-CTN special population committee, NAPAAC, AAACTT , SOHO-AAP
Awards
- Top Doctors in Cleveland 2014-2025 - Cleveland Magazine
- U.S. News Top Doctor, Castle Connolly Medical Ltd, 2014 to 2025
- Deborah Kredich Award - Duke University Medical Center - 2006
- Resident Teaching Award- Duke University Medical Center 2007
- Bassel Distinguished Excellence award for top 3 students - Aleppo University 1996, 1998 and 2000
- Flying Pig Award, Residency Program Director award - Duke University Medical Center -2006
- James A. Stockman III Award- Duke University Medical Center -2007
- Corkery Fellowship Award- University of Washington/ Fred-Hutchinson Cancer Research Center- 2009
- Best Teacher award – resident graduation Keynote speaker - Cleveland Clinic Children’s 2014
Professional Memberships
Research & Publications
See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.
As of 2026-03-27, Dr. Hanna has reported the financial relationships with the companies listed below.
Consulting and/or Speaking. Dr. Hanna receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:
- Vertex Pharmaceuticals Incorporated
- Swedish Orphan Biovitrum AB (Sobi)
- Chiesi USA, Inc.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.